• Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test

    Lilly acquired pegilodecakin as part of its 2018 purchase of Redwood City, CA-based Armo BioSciences. Armo’s approach to cancer treatment …

    Read More
  • 0 0